Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Notable Labs, Ltd. (NTBLQ)
:NTBLQ
Holding NTBLQ?
Track your performance easily
NTBLQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $1.94
Previous CloseN/A
Volume3.06K
Average Volume (3M)52.06K
Market Cap
$9.66K
Enterprise ValueN/A
Total Cash (Recent Filing)$45.25M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.46
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding9,659,496
10 Day Avg. Volume34,519
30 Day Avg. Volume52,056
Standard Deviation0.96
R-Squared1.00
Alpha0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.03
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
6.48% Insiders
0.30% Mutual Funds
3.49% Other Institutional Investors
89.73% Public Companies and
Individual Investors
NTBLQ FAQ
What was Notable Labs, Ltd.’s price range in the past 12 months?
Notable Labs, Ltd. lowest stock price was <$0.01 and its highest was $1.94 in the past 12 months.
What is Notable Labs, Ltd.’s market cap?
Notable Labs, Ltd.’s market cap is $9.66K.
When is Notable Labs, Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Notable Labs, Ltd.’s earnings last quarter?
Currently, no data Available
Is Notable Labs, Ltd. overvalued?
According to Wall Street analysts Notable Labs, Ltd.’s price is currently Overvalued.
Does Notable Labs, Ltd. pay dividends?
Notable Labs, Ltd. does not currently pay dividends.
What is Notable Labs, Ltd.’s EPS estimate?
Notable Labs, Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Notable Labs, Ltd. have?
Notable Labs, Ltd. has 9,659,496 shares outstanding.
What happened to Notable Labs, Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Notable Labs, Ltd.?
Currently, no hedge funds are holding shares in NTBLQ
---
Company Description
Notable Labs, Ltd.
Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of first-in-class treatments for cancer. It offers different programs for cancer and inflammatory disease patients such as vascular targeting system and Lecinoxoids. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.
---
Technical Analysis
Advaxis
―
Cellectar Biosciences
―
Molecular Templates
―
Kura Oncology
―
Voyager Therapeutics
―
---